JPMorgan Chase & Co. Has $571.22 Million Stock Holdings in Leidos Holdings, Inc. (NYSE:LDOS)

JPMorgan Chase & Co. lifted its holdings in shares of Leidos Holdings, Inc. (NYSE:LDOS) by 13.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,504,392 shares of the aerospace company’s stock after purchasing an additional 405,256 shares during the quarter. JPMorgan Chase & Co. owned approximately 2.63% of Leidos worth $571,216,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Fiduciary Trust Co grew its holdings in Leidos by 36.4% during the third quarter. Fiduciary Trust Co now owns 23,941 shares of the aerospace company’s stock valued at $3,902,000 after purchasing an additional 6,395 shares during the last quarter. Atria Investments Inc grew its stake in Leidos by 100.1% in the 3rd quarter. Atria Investments Inc now owns 8,837 shares of the aerospace company’s stock valued at $1,440,000 after buying an additional 4,421 shares during the last quarter. Allspring Global Investments Holdings LLC raised its holdings in Leidos by 51.2% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 837,370 shares of the aerospace company’s stock worth $136,491,000 after acquiring an additional 283,558 shares during the period. Los Angeles Capital Management LLC lifted its position in Leidos by 21.4% during the 3rd quarter. Los Angeles Capital Management LLC now owns 55,165 shares of the aerospace company’s stock worth $8,992,000 after acquiring an additional 9,710 shares during the last quarter. Finally, Rockefeller Capital Management L.P. bought a new stake in Leidos during the third quarter valued at about $4,622,000. Institutional investors and hedge funds own 76.12% of the company’s stock.

Analyst Ratings Changes

LDOS has been the subject of several recent analyst reports. JPMorgan Chase & Co. increased their target price on Leidos from $175.00 to $185.00 and gave the company an “overweight” rating in a research note on Wednesday, October 2nd. The Goldman Sachs Group cut shares of Leidos from a “buy” rating to a “neutral” rating and cut their target price for the company from $228.00 to $153.00 in a research note on Thursday, December 12th. Royal Bank of Canada raised their price target on shares of Leidos from $145.00 to $180.00 and gave the stock a “sector perform” rating in a research report on Wednesday, October 30th. Robert W. Baird increased their target price on shares of Leidos from $180.00 to $218.00 and gave the company an “outperform” rating in a research note on Wednesday, October 30th. Finally, UBS Group assumed coverage on Leidos in a research report on Monday, December 2nd. They set a “neutral” rating and a $182.00 price objective on the stock. Four analysts have rated the stock with a hold rating, nine have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $182.00.

Insider Buying and Selling at Leidos

In other news, Director Surya N. Mohapatra sold 2,748 shares of Leidos stock in a transaction on Thursday, November 7th. The shares were sold at an average price of $194.97, for a total transaction of $535,777.56. Following the transaction, the director now directly owns 20,001 shares of the company’s stock, valued at $3,899,594.97. This trade represents a 12.08 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Noel B. Geer bought 2,000 shares of Leidos stock in a transaction on Wednesday, November 20th. The shares were acquired at an average price of $161.13 per share, for a total transaction of $322,260.00. Following the completion of the acquisition, the director now owns 2,000 shares of the company’s stock, valued at approximately $322,260. This represents a ∞ increase in their position. The disclosure for this purchase can be found here. Insiders own 0.96% of the company’s stock.

Leidos Stock Performance

Leidos stock opened at $144.49 on Friday. Leidos Holdings, Inc. has a 12-month low of $106.38 and a 12-month high of $202.90. The stock has a market capitalization of $19.28 billion, a price-to-earnings ratio of 16.46, a P/E/G ratio of 1.04 and a beta of 0.64. The company has a quick ratio of 1.15, a current ratio of 1.23 and a debt-to-equity ratio of 0.87. The stock has a 50-day simple moving average of $166.68 and a 200 day simple moving average of $157.71.

Leidos (NYSE:LDOS) last issued its quarterly earnings results on Tuesday, October 29th. The aerospace company reported $2.93 earnings per share for the quarter, beating analysts’ consensus estimates of $1.96 by $0.97. Leidos had a net margin of 7.37% and a return on equity of 30.31%. The business had revenue of $4.19 billion during the quarter, compared to analyst estimates of $4.06 billion. During the same quarter last year, the business posted $2.03 earnings per share. Leidos’s revenue for the quarter was up 6.9% compared to the same quarter last year. On average, research analysts anticipate that Leidos Holdings, Inc. will post 9.89 earnings per share for the current fiscal year.

Leidos Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 31st. Shareholders of record on Monday, December 16th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Monday, December 16th. This is an increase from Leidos’s previous quarterly dividend of $0.38. This represents a $1.60 dividend on an annualized basis and a yield of 1.11%. Leidos’s dividend payout ratio is presently 18.22%.

Leidos Profile

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.